|
Galang, Christina K; Muller, William J; Foos, Gabriele et al. (2004) Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem 279:11281-92
|
|
Hever, Aniko; Oshima, Robert G; Hauser, Craig A (2003) Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro. Exp Cell Res 290:132-43
|
|
Foos, G; Galang, C K; Zheng, C F et al. (2001) Ras signaling to transcription activation: analysis with GAL4 fusion proteins. Methods Enzymol 333:61-73
|
|
Foos, G; Hauser, C A (2000) Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness. Oncogene 19:5507-16
|
|
Foos, G; Garcia-Ramirez, J J; Galang, C K et al. (1998) Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J Biol Chem 273:18871-80
|
|
McCarthy, S A; Chen, D; Yang, B S et al. (1997) Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol Cell Biol 17:2401-12
|
|
Yang, B S; Hauser, C A; Henkel, G et al. (1996) Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol 16:538-47
|
|
Galang, C K; Garcia-Ramirez, J; Solski, P A et al. (1996) Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem 271:7992-8
|
